MARKET

ARCT

ARCT

Arcturus
NASDAQ

Real-time Quotes | Nasdaq Last Sale

11.51
-0.44
-3.68%
Opening 13:34 01/24 EST
OPEN
11.94
PREV CLOSE
11.95
HIGH
12.21
LOW
11.36
VOLUME
24.55K
TURNOVER
--
52 WEEK HIGH
15.50
52 WEEK LOW
4.255
MARKET CAP
174.09M
P/E (TTM)
-8.1337
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of ARCT and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 6 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

ARCT News

  • The Arcturus Therapeutics Holdings (NASDAQ:ARCT) Share Price Has Gained 114%, So Why Not Pay It Some Attention?
  • Simply Wall St..01/10 10:47
  • Arcturus Therapeutics Appoints Steve Hughes, M.D., as Chief Development Officer
  • GlobeNewswire.01/08 12:00
  • Hedge Funds Have Never Been This Bullish On Arcturus Therapeutics Ltd. (ARCT)
  • Insider Monkey.12/19/2019 20:49
  • Arcturus Therapeutics (ARCT) Investor Presentation - Slideshow
  • Seeking Alpha - Article.12/18/2019 20:24

More

Industry

Biotechnology & Medical Research
-2.23%
Pharmaceuticals & Medical Research
-1.61%

Hot Stocks

Name
Price
%Change

About ARCT

Arcturus Therapeutics Ltd. is a ribonucleic acid (RNA) medicines company. The Company owns Lipid-enabled and Unlocked Nucleomonomer Agent modified RNA (LUNAR) lipid-mediated delivery and Unlocked Nucleomonomer Agent (UNA) technology, including UNA Oligomers. The Company’s diverse pipeline of RNA therapeutics includes programs pursuing rare diseases, Hepatitis B, non-alcoholic steatohepatitis (NASH), cystic fibrosis and vaccines. The Company’s versatile RNA therapeutics platforms can be applied toward multiple types of RNA medicines, including small interfering RNA, messenger RNA, replicon RNA, antisense RNA, microRNA and gene editing therapeutics. The Company's UNA technology can be used to target individual genes in the human genome, as well as viral genes, and other species for therapeutic purposes.
More

Webull offers Arcturus Therapeutics Ltd (ARCT) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.